Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gliomas, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchWithdrawnNCT04220892
What this trial is testing

Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma

Who this might be right for
High Grade Glioma
Jose Carrillo
Testing effectiveness (Phase 2)UnknownNCT04547621
What this trial is testing

HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM

Who this might be right for
Glioma, Malignant
Huashan Hospital 50
Not applicableLooking for participantsNCT04543201
What this trial is testing

Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma

Who this might be right for
Glioma
University of Rochester 50
Not applicableStudy completedNCT06914700
What this trial is testing

A Nomogram for Predicting the Diagnosis of Central Malignant Tumors Based on Preoperative Clinical Characteristics and Laboratory Indicators:

Who this might be right for
Central Malignant TumorsPCNSLGlioma+1 more
Guangdong Provincial People's Hospital 800
Early research (Phase 1)Study completedNCT00017264
What this trial is testing

Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT01235845
What this trial is testing

Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma

Who this might be right for
Malignant Glioma
Qingdao University 30
Early research (Phase 1)Study completedNCT01392209
What this trial is testing

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

Who this might be right for
Brain CancerMALIGNANT GLIOMAGlioblastoma+5 more
Memorial Sloan Kettering Cancer Center 15
Early research (Phase 1)Study completedNCT01248949
What this trial is testing

Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsAdvanced Recurrent Ovarian Tumors
MedImmune LLC 162
Not applicableLooking for participantsNCT07612917
What this trial is testing

Brain Connectivity Changes in Glioma Patients During Treatment

Who this might be right for
Glioma (Any Grade) in the BrainGliomas, MalignantfMRI Research+1 more
Johannes Kepler University of Linz 20
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06763965
What this trial is testing

Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.

Who this might be right for
Recurrent High-grade Glioma
Beijing Bio-Targeting Therapeutics Technology Co., Ltd 30
Not applicableNot Yet RecruitingNCT07590726
What this trial is testing

PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors

Who this might be right for
Brain Injuries, AcuteBrain Tumor AdultBrain (Nervous System) Cancers+4 more
Rigshospitalet, Denmark 160
Testing effectiveness (Phase 2)Looking for participantsNCT05683808
What this trial is testing

Venous Thromboembolism Prevention in Outpatients With Glioma

Who this might be right for
GlioblastomaAstrocytomaVenous Thromboembolism
University of Vermont Medical Center 40
Large-scale testing (Phase 3)Study completedNCT02892708
What this trial is testing

Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over

Who this might be right for
Malignant Glioma
Assistance Publique - Hôpitaux de Paris 107
Testing effectiveness (Phase 2)Study completedNCT00939991
What this trial is testing

Suberoylanilide Hydroxamic Acid (SAHA), Bevacizumab, Daily Temozolomide for Recurrent Malignant Gliomas

Who this might be right for
Brain TumorGlioblastoma
Katy Peters 48
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT00147160
What this trial is testing

Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents

Who this might be right for
Glioma
Gustave Roussy, Cancer Campus, Grand Paris 87
Early research (Phase 1)WithdrawnNCT04521946
What this trial is testing

Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer

Who this might be right for
Anaplastic EpendymomaAtypical Teratoid/Rhabdoid TumorCentral Nervous System Germ Cell Tumor+12 more
M.D. Anderson Cancer Center
Not applicableStudy completedNCT04734444
What this trial is testing

SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue

Who this might be right for
Brain TumourHigh Grade GliomaLow-grade Glioma+1 more
SonoClear AS 45
Early research (Phase 1)Study completedNCT01316809
What this trial is testing

AZD8055 for Adults With Recurrent Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+2 more
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT03210714
What this trial is testing

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Childhood Malignant Germ Cell Tumor+29 more
National Cancer Institute (NCI) 20
Next Page